Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Xenon Pharmaceuticals Inc.
< Previous
1
2
3
Next >
Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025
December 05, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
December 03, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
November 25, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at Upcoming Investor Conferences
November 06, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Reports Third Quarter 2025 Financial Results & Business Update
November 03, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Report Q3 2025 Financial Results on November 3, 2025
October 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
October 16, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 07, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
September 25, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 29, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Reports Second Quarter 2025 Financial Results & Business Update
August 11, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Report Q2 2025 Financial Results on August 11, 2025
August 04, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Joins the Russell 3000® and Russell 2000® Indexes
June 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Announces Appointment of Darren Cline as Chief Commercial Officer
June 24, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
June 03, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 30, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference
May 14, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Report Q1 2025 Financial Results on May 12, 2025
May 05, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 02, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025
April 04, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at Stifel 2025 Virtual CNS Forum
March 12, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Reports Fourth Quarter & Full Year 2024 Financial Results and Business Update
February 27, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at the 45th Annual TD Cowen Healthcare Conference
February 25, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Report Q4 and Full Year 2024 Financial Results on February 27, 2025
February 20, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon Outlines Key Corporate Milestone Opportunities for 2025
January 13, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
Xenon to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
Xenon Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
XENE
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.